• Explore /
  • Poster
  • / Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01).

Abstract Poster

Authors

null

Robert William Lentz

University of Colorado Cancer Center, Aurora, CO;

Robert William Lentz , Junxiao Hu , Patrick Jud Blatchford , Todd Pitts , Alexis Diane Leal , Sunnie S. Kim , S. Lindsey Davis , Christopher Hanyoung Lieu , Aaron James Scott , Patrick M Boland , Howard S. Hochster , Wells A. Messersmith

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05167409

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS257)

DOI

10.1200/JCO.2023.41.4_suppl.TPS257

Abstract #

TPS257

Poster Bd #

N19

Abstract Disclosures

Similar Posters

First Author: Atsushi Ishiguro

First Author: Georg Martin Haag

First Author: Hirokazu Shoji

First Author: Tomohiro Kondo